We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves a Novel Medicine Invented at Scripps Research, for Treatment of Multiple Sclerosis

News   Mar 30, 2020 | Original story by Scripps Research

 
FDA Approves a Novel Medicine Invented at Scripps Research, for Treatment of Multiple Sclerosis
 
 
Advertisement
 

RELATED ARTICLES

Proteins in the Blood of COVID-19 Patients Could Help Predict How Ill They Will Become

News

Researchers have found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending on the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.

READ MORE

Out-of-Sync Brain Waves May Underlie Learning Deficit Linked to Schizophrenia

News

A new study has pinpointed a specific pattern of brain waves that underlies the ability to let go of old, irrelevant learned associations to make way for new updates.

READ MORE

New Study Elucidate a Molecular Mechanism That Causes Differences in Drug Addiction, Making Some More Prone

News

Researchers have discovered that dopamine D2 receptors (DRD2s) in cholinergic interneurons (ChINs) play a crucial role in cocaine addiction.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE